loadpatents
name:-0.015997171401978
name:-0.012625932693481
name:-0.0094189643859863
Lawson; Alastair Patent Filings

Lawson; Alastair

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lawson; Alastair.The latest application filed is for "antibody epitope".

Company Profile
8.11.16
  • Lawson; Alastair - Slough GB
  • LAWSON; Alastair - Slough Berkshire GB
  • Lawson; Alastair - Alresford GB
  • Lawson; Alastair - Hampshire GB
  • Lawson; Alastair - Glenrothes SC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for identifying a modulator of the TNF.alpha. or CD40L interaction with their cognate receptors
Grant 11,448,655 - O'Connell , et al. September 20, 2
2022-09-20
Antibody Epitope
App 20220074947 - O'CONNELL; James Philip ;   et al.
2022-03-10
Antibodies binding to trimeric TNF alpha epitopes
Grant 11,022,614 - O'Connell , et al. June 1, 2
2021-06-01
Mechanism Of Action
App 20210140972 - O'CONNELL; James Philip ;   et al.
2021-05-13
Antibody
App 20210132079 - O'CONNELL; James Philip ;   et al.
2021-05-06
Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
Grant 10,969,393 - O'Connell , et al. April 6, 2
2021-04-06
NOVEL TNFa STRUCTURE FOR USE IN THERAPY
App 20210088530 - O'CONNELL; James Philip ;   et al.
2021-03-25
Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
Grant 10,935,553 - O'Connell , et al. March 2, 2
2021-03-02
Methods of identifying signaling modulators of the trimeric TNFa
Grant 10,883,996 - O'Connell , et al. January 5, 2
2021-01-05
Modulator Assay
App 20200400678 - O'CONNELL; James Philip ;   et al.
2020-12-24
Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
Grant 10,775,385 - O'Connell , et al. Sept
2020-09-15
TNF receptor signaling modulator assay
Grant 10,705,094 - O'Connell , et al.
2020-07-07
NOVEL TNFalpha STRUCTURE FOR USE IN THERAPY
App 20180231562 - O'CONNELL; James Philip ;   et al.
2018-08-16
Mechanism Of Action
App 20180203016 - O'CONNELL; James Philip ;   et al.
2018-07-19
Antibody Epitope
App 20180172701 - O'CONNELL; James Philip ;   et al.
2018-06-21
Modulator Assay
App 20180172702 - O'CONNELL; James Philip ;   et al.
2018-06-21
Antibody
App 20180171008 - O'CONNELL; James Philip ;   et al.
2018-06-21
Antibody-based Diagnostics And Therapeutics
App 20130203968 - Robinson; Martin K. ;   et al.
2013-08-08
Epitopes
App 20110305702 - LU; HSIENG S. ;   et al.
2011-12-15
Sclerostin epitopes
Grant 8,003,108 - Lu , et al. August 23, 2
2011-08-23
Binding Agents
App 20110097342 - Paszty; Christopher J. ;   et al.
2011-04-28
Sclerostin-binding antibodies
Grant 7,872,106 - Paszty , et al. January 18, 2
2011-01-18
Binding Agents
App 20090304713 - Paszty; Christoper ;   et al.
2009-12-10
Sclerostin-binding antibody
Grant 7,592,429 - Paszty , et al. September 22, 2
2009-09-22
Binding agents
App 20070110747 - Paszty; Christopher ;   et al.
2007-05-17
Epitopes
App 20070072797 - Robinson; Martyn Kim ;   et al.
2007-03-29
Apparatus for recording and reproducing information with respect to a flexible recording medium
Grant 4,085,428 - Green , et al. April 18, 1
1978-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed